Bayer
Diversified life sciences company spanning pharmaceuticals, consumer health and agriculture.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- Bayer AG
- Entity type
- COMPANY
- Founded
- 1863
- Company size
- >5,000
- Market role
- Advertiser / Brand
- Ticker
- BAYN
- Official website
- bayer.com
What Bayer does
Bayer creates value by researching, manufacturing, commercialising and distributing life sciences products across healthcare and agriculture. Its business model is built around product innovation, regulatory approvals, branded portfolios, large-scale manufacturing, channel distribution and recurring demand for medicines, health products and crop-related inputs.
Category differentiation
This is the German life sciences group, not an adtech, martech or media company. It should not be confused with a software platform, agency or publisher brand.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Bayer is a diversified life sciences company best known for operating across prescription medicines, consumer health products and agricultural inputs. It generates revenue primarily from selling branded and portfolio-based products through healthcare, pharmacy, retail and agricultural channels rather than from advertising, media, software or agency services. Its customers span healthcare providers, wholesalers, pharmacies, retailers, farmers and agricultural distribution partners, with some products ultimately reaching consumers. Based on the limited input provided, Bayer should be understood as a large operating company in healthcare and agriculture rather than a martech, adtech, publishing or SaaS business.
Company news briefing
Briefing updated:
Bayer is advancing its seed and crop protection pipeline alongside blockbuster launches, complemented by a commercial agreement with Neste to scale newgold winter canola for biofuels. In media strategy, Bayer's Consumer Health brand Iberogast successfully shifted TV budgets to YouTube Connected TV to boost reach, while executives highlighted inconsistent measurement standards as a barrier to retail media investment. Additionally, Bayer continues to leverage fine-tuned local AI models for proprietary regulatory queries, while its proposed up-to-$7.25 billion Roundup settlement remains pending final approval.
Business model & monetisation
The company monetises through direct product sales, channel sales and wholesale distribution across regulated life sciences markets. Revenue is typically driven by product volume, brand strength, patent- or formulation-based differentiation, and repeat purchasing through healthcare and agricultural supply chains rather than SaaS subscriptions or media monetisation.
Products & capabilities
No products with linked sources are available in this view.
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
Iberogast's Big Screen YouTube Strategy Boosts Reach by 17 Points
CTV, Media Planning · Recorded impact score: 3/5
At the YouTube Festival 2026, Bayer's Consumer Health brand Iberogast presented a case study on shifting TV budget to YouTube to reach younger audiences. Facing an awareness gap among 25-44 year-olds, Bayer used Google's DV360 Reach Planner to model an integrated cross-media plan. The recommendation was to shift 30% of the TV budget to YouTube, targeting Connected TV (Big Screen) with non-skippable ads. The campaign achieved a net reach of 67%, 17 percentage points higher than a pure TV campaign, exactly as predicted. Brand Lift data showed a 41% increase in ad recall and a 7% increase in purchase intent. This pilot has become the new standard for Bayer Consumer Health, which now orchestrates a holistic Big Screen strategy across its brand portfolio, planning linear TV and YouTube together.
- Bayer shifted 30% of Iberogast's TV budget to YouTube as recommended by Google's DV360 Reach Planner.
- The campaign reached 67% net reach in target audience, 17 percentage points higher than a TV-only campaign.
YouTube Festival 2026: Brands See 90% More ROI Than TV
Platform · Recorded impact score: 2/5
At the YouTube Festival 2026 in Berlin, Google executives and brand marketers highlighted YouTube's growing importance in media planning. Philipp Justus, Google's VP Central Europe, emphasized YouTube's cultural influence, while Marianne Stroehmann presented data showing 90% more ROI compared to TV. Case studies from E.ON and Nestlé demonstrated successful creator collaborations and the effectiveness of YouTube in driving brand consideration and conversions. Bayer's media planning with Display & Video 360 increased reach from 45% to 67%. The event underscored a paradigm shift from traditional TV advertising to creator-driven, culturally embedded content on YouTube.
- Google's YouTube Festival 2026 took place in Berlin on September 17, 2026.
- YouTube reportedly delivers 90% more ROI than TV according to Google.
Bayer and Neste close commercial agreement to jointly scale newgold® winter canola for biofuels production
Recorded impact score: 4/5
Bayer and Neste have closed a commercial agreement to jointly scale newgold® winter canola for biofuels production, marking a major strategic partnership in renewable fuels.
Bayer advances combined seed and crop protection pipeline and enters phase of blockbuster launches
Recorded impact score: 4/5
Bayer announced on September 02, 2026 that it is advancing its combined seed and crop protection pipeline and entering a phase of blockbuster launches.
Chalice AI: Brand-Specific Models for Programmatic
Programmatic / AI · Recorded impact score: 2/5
This AdExchanger Talks podcast episode features Ali Manning, COO and co-founder of Chalice AI, discussing the company's approach to letting brands bring their own models into walled gardens, DSPs and SSPs. Chalice positions its software as continuously running, refreshable models (including generative AI) that optimize for brand-specific business outcomes rather than standard proxies like clicks or video completion. Manning describes challenges around the term "custom algorithm," explains Chalice's origin story, and gives a client example (Bayer’s One A Day) where Chalice used AI modelling and DSP bidding to drive offline "new to brand" sales. The conversation also touches on containerization and agentic bidding as possible ways to realize more precise programmatic outcomes.
- The article is a podcast interview with Ali Manning, COO & Co-Founder of Chalice AI.
- Chalice AI is described as a startup that enables brands to bring their own models into walled gardens, DSPs and SSPs.
Explore company relationships
Questions about Bayer
What is Bayer?
Bayer is a diversified life sciences company operating in pharmaceuticals, consumer health and agricultural products.
Who uses Bayer?
Its products are bought or prescribed through healthcare providers, pharmacies, retailers, farmers and agricultural distribution channels, with some products ultimately used by consumers.
How does Bayer make money?
It makes money primarily by selling medicines, health products and agricultural inputs through regulated commercial channels and distribution networks.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
13 publicly documented primary sources and citations linked across the market graph.
Continue your research on Bayer
Explorer includes additional company details, a Watchlist for up to 25 companies and your personal Strategic Intelligence Agent. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Free, with no time limit.